350% Upside. Favorable Descending Triangle.It has been in that triangle for almost 2 years now. Tagged the bottom of the triangle multiple times and could break upward out of the triangle. And RFK jr. policies favor this.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.80 USD
−40.22 M USD
314.00 K USD
117.06 M
About ATAI Life Sciences N.V.
Sector
Headquarters
Berlin
Founded
2018
Website
ISIN
NL0015000DX5
FIGI
BBG0107FR3K9
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.
ATAI Life Sciences | ATAI | Long at $1.30ATAI Life Sciences NASDAQ:ATAI , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is
High potential over the coming yearsPositioned to disrupt the medicinal industry with its wide range of products and significant stakes in other biotech companies like Compass. ATAI possess ample funds to quickly become a leader in a market that has not yet fully emerged. High Volatility I wouldn't be surprised to see the stock reach
ATAI - 2 potential paths to $5After successfully surpassing the previous swing high with considerable volume, attaining a fresh 52-week peak of $2.85, and witnessing the 50-day moving averages intersecting the 150 and 200 SMAs, ATAI appears poised for a reversal from its downtrend.
**Potential Scenarios:**
**Scenario 1: Triang
ATAI looking to bottom out
After closely monitoring psychedelic stocks for approximately six months, my attention has been drawn to ATAI. Despite enduring a challenging period over the past couple of years, the stock appears to be signaling a potential turnaround.
Volume Analysis
A notable observation is the diminishing v
similar to mindmed mush and psychedelics have good opportunity The opportunity is there, again similar to mmed stock. Mush and pyschadelics have a good potential in future. Bullish on this stock. just waiting for the correct technical set up. Might have to wait a few weeks for a play. but seems decent
ataiATAI LIFE SCIENCES. MUSHROOMS CLEARED MY ALCOHOL ADDICTION THIS YEAR, PSYCHEDILICS ARE THE REAL CURE FOR ADDICTION ANXIETY DEPRESSION ETC. This is one of the top companies.
This isn't a trade for me, I plan on holding long term but this is a very nice set up.
ATAI short-term playHello bulls,
This one is a short-term play and can't much be said about it.
After CMPS crushed, price dropped to 12$ and then due to Macro economical panic, crabbed around 11$.
This is good that it's crabbing around 11$ because the next steps are the slow stairs to the 15$.
Volume on last hour of D
$ATAI consolidating from wedge breakoutThis is one that I really look forward to. My conviction is fueled by the following:
- Belief in small mid caps outperforming following weeks
- Observation that new IPOs breaking out of downward wedge seem to be high probability plays
- All the short squeeze momo plays have a high chance of rotating
ATAI - long psychedelics If youre interessted or believe in psychedelics as medicine, its maybe a good buying oppurtunity for a longshot in ATAI. You could play it with a stop or not - personally I dont have a stop but checking it manually - if the level hold it can be a great longterm oppurtunity - personally I have a smal
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATAI is 1.29 USD — it has increased by 2.40% in the past 24 hours. Watch ATAI Life Sciences N.V. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ATAI Life Sciences N.V. stocks are traded under the ticker ATAI.
ATAI stock has risen by 7.56% compared to the previous week, the month change is a −23.35% fall, over the last year ATAI Life Sciences N.V. has showed a −13.18% decrease.
We've gathered analysts' opinions on ATAI Life Sciences N.V. future price: according to them, ATAI price has a max estimate of 11.00 USD and a min estimate of 5.00 USD. Watch ATAI chart and read a more detailed ATAI Life Sciences N.V. stock forecast: see what analysts think of ATAI Life Sciences N.V. and suggest that you do with its stocks.
ATAI reached its all-time high on Jun 18, 2021 with the price of 22.91 USD, and its all-time low was 1.02 USD and was reached on Dec 1, 2023. View more price dynamics on ATAI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATAI stock is 6.20% volatile and has beta coefficient of 1.85. Track ATAI Life Sciences N.V. stock price on the chart and check out the list of the most volatile stocks — is ATAI Life Sciences N.V. there?
Today ATAI Life Sciences N.V. has the market capitalization of 214.79 M, it has increased by 4.24% over the last week.
Yes, you can track ATAI Life Sciences N.V. financials in yearly and quarterly reports right on TradingView.
ATAI Life Sciences N.V. is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
ATAI earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.16 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.14 USD per share. See more details about ATAI Life Sciences N.V. earnings.
ATAI Life Sciences N.V. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 300.00 K USD.
ATAI net income for the last quarter is −26.29 M USD, while the quarter before that showed −57.31 M USD of net income which accounts for 54.14% change. Track more ATAI Life Sciences N.V. financial stats to get the full picture.
No, ATAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 83.00 employees. See our rating of the largest employees — is ATAI Life Sciences N.V. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ATAI Life Sciences N.V. EBITDA is −105.53 M USD, and current EBITDA margin is −39.86 K%. See more stats in ATAI Life Sciences N.V. financial statements.
Like other stocks, ATAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ATAI Life Sciences N.V. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ATAI Life Sciences N.V. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ATAI Life Sciences N.V. stock shows the sell signal. See more of ATAI Life Sciences N.V. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.